Log in to save to my catalogue

SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom

SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_60e712d804184440a68075e288724e11

SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom

About this item

Full title

SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom

Publisher

United States: U.S. National Center for Infectious Diseases

Journal title

Emerging infectious diseases, 2023-06, Vol.29 (6), p.1223-1227

Language

English

Formats

Publication information

Publisher

United States: U.S. National Center for Infectious Diseases

More information

Scope and Contents

Contents

Anthropogenic transmission of SARS-CoV-2 to pet cats highlights the importance of monitoring felids for exposure to circulating variants. We tested cats in the United Kingdom for SARS-CoV-2 antibodies; seroprevalence peaked during September 2021-February 2022. The variant-specific response in cats trailed circulating variants in humans, indicating...

Alternative Titles

Full title

SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_60e712d804184440a68075e288724e11

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_60e712d804184440a68075e288724e11

Other Identifiers

ISSN

1080-6040,1080-6059

E-ISSN

1080-6059

DOI

10.3201/eid2906.221755

How to access this item